A leading biotechnology company in Matrix Therapy
A new branch of Regenerative Medicine

liseret1
liseret2

About us

About us

We are a clinical-stage regenerative medical device company founded by leading biologists Prof Denis Barritault and Prof Jean-Pierre Caruelle. Through their pioneering work on growth factors (the discovery of FGF, HARP/PTN) they invented RGTA® Technology (ReGeneraTing Agents), a new therapeutic class in regenerative medicine. OTR3 currently markets three products :

  • Cacipliq® for wound healing (CE marked medical devices)
  • Clerapliq for corneal lesions in animals.
  • Dermapliq for skin lesions in animals

The RGTA® Technology is patented worldwide.

aboutus2

Our Goals

Our Goals

OTR3 is committed to explore the full potential of the RGTA® Technology by developing new indications and innovative healthcare products. Our expansion relies on extensive cutting-edge research and development that will allow to bring significant benefits for a large number of patients.

OTR3 enlarges its portfolio of new products thanks to his capabilities to design new RGTA® molecules for the treatment of targeted diseases.

OTR3 commercializes its products through distribution partnerships or out- licensing.

Our Mission

Our Mission

To bring to market comprehensive regenerative solutions for the treatment of dermatological and neurological diseases with large unmet medical needs and  feed the pipeline for futur indication.

Our Team

Our Team

OTR3’s management team includes industry veterans with a wealth of experience and a commitment to driving OTR3 forward as the leading developer of novel regenerative matrix therapies.

Management Team

Steering Board

A steering board, composed of recognised professionals, assists OTR3’s team providing scientific, business and strategic advice.

Pr Dulce PAPY

Director CRRET (CNRS Laboratory)

Alain ROUSSEAU

C.E.O of Arteion

Yannick Pletan

Fomer Chief Medical Officer of major pharmas and Medical Consultant

Dr Catherine CART-GRES

Chief Medical Officer, SOM Biotech

Nicolas WILLARD

Regional Sales Manager SWIFT

Gérard LIBERCIER

Senior VP Aventis – Integration Officer Sanofi-Aventis

Catherine MANTEL

VP Scale NGO, VP Terrawatt Initiative

liseret1
liseret2
About us

Organes Tissus Regeneration Reparation Remplacement

© 2022 – OTR3 – All rights reserved

ADDRESS

4, rue Française
75001 Paris, France

© 2022 – OTR3 – All rights reserved